NIOX Group Plc (FRA:82C)

Germany flag Germany · Delayed Price · Currency is EUR
0.785
+0.075 (10.56%)
Last updated: Dec 5, 2025, 11:30 AM CET
16.30%
Market Cap 341.61M
Revenue (ttm) 53.66M
Net Income (ttm) 6.07M
Shares Out n/a
EPS (ttm) 0.01
PE Ratio 56.31
Forward PE 28.96
Dividend 0.01 (2.03%)
Ex-Dividend Date May 15, 2025
Volume n/a
Average Volume n/a
Open 0.790
Previous Close 0.710
Day's Range 0.785 - 0.790
52-Week Range 0.585 - 0.885
Beta n/a
RSI 46.32
Earnings Date Dec 24, 2025

About NIOX Group

NIOX Group Plc engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide. It offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of Fractional Exhaled Nitric Oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. N... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2006
Employees 91
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 82C
Full Company Profile

Financial Performance

In 2024, NIOX Group's revenue was 41.80 million, an increase of 13.59% compared to the previous year's 36.80 million. Earnings were 3.70 million, a decrease of -65.42%.

Financial numbers in GBP Financial Statements

News

There is no news available yet.